18,4 %Total HIV prevalence was 18.4% in the general population sample of women aged 15–49 in the Siaya HDSS in western Kenya in 2018.
KenyaVIH/sidaobservé 2018publié 2023PloS onePubMeddocument de 2 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
6 677 evidences · page 48 / 268
18,4 %Total HIV prevalence was 18.4% in the general population sample of women aged 15–49 in the Siaya HDSS in western Kenya in 2018.
KenyaVIH/sidaobservé 2018publié 2023PloS onePubMeddocument de 2 observations
19 %Among women with HIV, the prevalence of high-grade cervical intraepithelial neoplasia (CIN2/3) was 19.0%.
Kenyahigh-grade cervical intraepithelial neoplasia (CIN2/3)publié 2025Sexually transmitted infectionsPubMeddocument de 12 observations
6,8 %HBV prevalence was 6.8% (95% CI: 1.7–11.8%) among persons in polygamous marriages in Kenya.
Kenyahépatite Bobservé 2018publié 2024PloS onePubMeddocument de 10 observations
50 %Among 10 enrollees who were unwilling to participate, five (50%) cited fear of vaccine adverse effects.
KenyaVIH/sidaobservé From February 2017 to May 2018publié 2026BMC public healthPubMeddocument de 10 observations
87 %After 19 months of follow-up, 65 out of 75 participants living with HIV (87%) were active in care.
KenyaVIH/sidapublié 2023BMC health services researchPubMeddocument de 12 observations
52,3 %The 3-year age-standardised net survival for cervical cancer was 52.3% in sub-Saharan Africa.
Kenyacancer du col de l'utéruspublié 2024The Lancet. Global healtheurope_pmcdocument de 12 observations
1,2 odds_ratioEvery additional hour of travel time to Nairobi from their county of residence resulted in a 20% increase in the odds of a cancer care delay (OR = 1.20, 95% CI: 1.06–1.36).
Kenyacancer (non précisé)publié 2022International journal of cancereurope_pmcdocument de 12 observationsDOI 10.1002/ijc.33910
42 %Among HIV-infected women self-reporting pregnancy/live birth, prevalence of viral suppression was 42% at baseline in intervention communities.
KenyaVIH/sidapublié 2020AIDS (London, England)PubMeddocument de 8 observations
1 casesIn Kenya, one of 68 listed mpox contacts developed symptoms and tested positive.
KenyampoxAfrica CDCdocument de 147 observations
12 %Among 487 adolescent girls and young women aged 15–24 years attending four public family planning clinics in Western Kenya from January to June 2019, 59 (12%) reported moderate-to-severe depression.
Kenyamoderate-to-severe depressionobservé January to June 2019publié 2020International journal of STD & AIDSPubMeddocument de 4 observations
33 %The prevalence of anaemia in the study population of patients with rheumatoid arthritis at Kenyatta National Hospital was 33%.
Kenyaanémie · Rheumatoid Arthritis (RA)observé September 2011 – March 2012publié 2015University of Nairobi Research Archive (University of Nairobi)OpenAlexdocument de 10 observations
18 US$The mean total unit cost of post-exposure prophylaxis (PEP) was US$18 in Kenya.
KenyaVIH/sidaobservé 2019publié 2023BMC health services researchPubMeddocument de 11 observations
57,7 %Recent significant life-events were prevalent in 57.7% of youth aged 15–24 years living with HIV in rural Kenya and Uganda.
KenyaVIH/sidapublié 2023AIDS carePubMeddocument de 7 observations
90 %From 1st July 2022 to 30th June 2023, treatment uptake for visual inspection with acetic acid (VIA) positive lesions improved from 38% pre-intervention to 90%.
Kenyacancer du col de l'utérusobservé 1st July 2022 to 30th June 2023publié 2025BMC women's healthPubMeddocument de 8 observations
15,6 %CHVs managed 15.6% of rapid diagnostic test-positive cases in Siaya County.
Kenyapaludismeobservé 2021-2023publié 2026Malaria journalPubMeddocument de 12 observations
Parasite density in parasitemic children negatively correlated with the composite cognitive score and measures of cognitive flexibility and attention.
Kenyapaludismepublié 2024Journal of the Pediatric Infectious Diseases SocietyPubMeddocument de 4 observations
0,73 prevalence_ratioNewly-diagnosed HIV was not associated with consistent versus inconsistent condom use, with a prevalence ratio of 0.73 (95% CI 0.25–2.10).
KenyaVIH/sidapublié 2024PloS onePubMeddocument de 6 observations
26 °CIn Kisumu using a time lag of 15 weeks in the GAMM, the relationship between malaria cases and temperature remained steady between 22 and 30 °C.
Kenyapaludismepublié 2025Malaria journalPubMeddocument de 8 observations
33,2 %Malaria was the most prevalent cause of death and constituted 33.2% of all causes of death among children under 5 years in Siaya County, Kenya, during 2003–2013.
Kenyapaludismeobservé 2003-2013publié 2023Malaria journalPubMeddocument de 8 observations
36 casesOf the 3345 participants enrolled, 36 biological males from Thailand were diagnosed with acute HIV infection.
Kenyahuman immunodeficiency virus infectionpublié 2022MedicinePubMeddocument de 12 observations
1,3 %The prevalence of pulmonary tuberculosis at enrollment was 1.3% among 383 people living with HIV in western Kenya.
Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 12 observations
0,48 ratioThe adjusted prevalence ratio of HIV in circumcised compared with uncircumcised men was 0.48 in Kisumu, Kenya.
KenyaVIH/sidapublié 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 4 observations
604 000 casesGlobally, there were about 604,000 new cervical cancer cases in 2020.
Kenyacancer du col de l'utérusobservé 2020publié 2023PloS onePubMeddocument de 16 observations
49 %Among HIV-infected HHV-8 seropositive Kenyan women, those with CD4 count ≥500 cells/mm³ had a HHV-8 shedding rate of 49%, compared to 12% for those with CD4 count <500 cells/mm³.
KenyaHHV-8 · VIH/sidapublié 2014Journal of medical virologyeurope_pmcdocument de 5 observations
Immunoglobulin G1 (IgG1) concentrations were significantly lower in cervicovaginal mucus samples from women with bacterial vaginosis compared to those without bacterial vaginosis.
Kenyavaginose bactériennepublié 2025Frontiers in immunologyPubMeddocument de 4 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.